Johnson & Johnson’s North America Global Services (GS) team is recruiting for the newly created Finance Lead position, supporting the NA Innovative Medicine Country Finance Manager (CFM) responsibilities supporting actuals from Global Services perspective. This role is based in Titusville, NJ and may require up to 10% local travel (domestic and/or international).
At Johnson & Johnson,?we believe health is everything. Our strength in healthcare innovation empowers us to build a?world where complex diseases are prevented, treated, and cured,?where treatments are smarter and less invasive, and?solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/ .
Johnson & Johnson Global Services, the global shared services organization supporting the businesses of Johnson & Johnson, performs select functional work in a consistent manner across regions and sectors using simplified, standardized end-to-end processes and state-of-the-art technology. The vision of Johnson & Johnson Global Services is “to be trusted business partners who deliver increasing value by creating and sustaining globally standard world-class services that enable the power of Johnson & Johnson.”
Role & Responsibilities:
This position will lead the Financial Accounting & Reporting responsibilities in support of the Country Finance Manager (CFM) core responsibilities in working across all tiers of the organization in ensuring financial statements are accurate for the NA Innovative Medicine commercial business.
This high exposure Finance Lead position will play a key role in leading the continued evolution of the CFM standardization efforts.
The individual will work closely with NA Innovative Medicine Commercial finance leadership team in the coordination and reporting of actual results for the business and serve as the ‘face of Global Services” to our business partners.
Key reporting responsibilities include ownership of the Trial Balance, coordination and execution of Income Statement and Balance Sheet Reviews, BS-75 reporting, and other related controls.
The individual will also play a leadership role in GS and other continuous improvement initiatives, such as SigniFi, to standardize and automate processes.
This individual will play a supervisory role to CFM Sr. Financial Analyst.
QUALIFICATIONS
A minimum of a bachelor’s degree, preferably a major in Accounting or Finance or another related field is required.
An advanced degrees or certifications such as MBA, CPA or CMA etc. is preferred.
A minimum of 4 years of finance or related business experience is required.
Experience with Microsoft Suite of products (Excel, PowerPoint, etc.), SAP and TM1 is preferred.
Ability to work independently, collaborate effectively, influence decision making, think creatively, challenge the status quo, and work across multiple teams. Individual must work well in a fast-paced, dynamic environment with all levels of the organization and be able to recommend and implement process improvements is required.
Ability to take on leadership roles in various initiatives and effectively handle multiple tasks simultaneously is required.
This position is based in Titusville, NJ and may require up to 10% local travel (domestic and/or international)
New Brunswick, New Jersey
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women’s health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.
The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery.
The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.